Zenas Biopharma Inc (ZBIO) - News Archive

ZBIO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces Class Action Lawsuit for Zenas BioPharma, Inc. Shareholders In a significant development within the pharmaceutical sector, Robbins Geller Rudman & Dowd LLP...

In a significant development for investors in Zenas BioPharma, Inc. (NASDAQ: ZBIO), Rosen Law Firm, a prominent global investor rights law firm, is urging shareholders to secure legal counsel ahead of a critical deadlin...

Zenas BioPharma s Stock Options Riddle Amid Financial ScrutinyBy Author Name | CSI MarketApril 18, 2025 — In a move that has raised eyebrows within the biopharmaceutical community, Zenas BioPharma, Inc. (Nasdaq: ZBIO) a...

Zenas BioPharma, Inc. (NASDAQ: ZBIO) has recently come under scrutiny due to potential discrepancies in its disclosed business information, which have raised concerns among shareholders and industry analysts alike. This...

In a significant development concerning corporate accountability and investor protection, the Rosen Law Firm, a renowned global investor rights law firm, announced its probe into the intricacies surrounding Zenas BioPha...